| Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology A Zimprich, S Biskup, P Leitner, P Lichtner, M Farrer, S Lincoln, ... Neuron 44 (4), 601-607, 2004 | 3186 | 2004 |
| A double‐blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease CW Olanow, CG Goetz, JH Kordower, AJ Stoessl, V Sossi, MF Brin, ... Annals of neurology 54 (3), 403-414, 2003 | 1783 | 2003 |
| Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease R De la Fuente-Fernández, TJ Ruth, V Sossi, M Schulzer, DB Calne, ... Science 293 (5532), 1164-1166, 2001 | 1205 | 2001 |
| Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease AE Lang, S Gill, NK Patel, A Lozano, JG Nutt, R Penn, DJ Brooks, ... Annals of neurology 59 (3), 459-466, 2006 | 1058 | 2006 |
| Slower progression of Parkinson's disease with ropinirole versus levodopa: the REAL‐PET study AL Whone, RL Watts, AJ Stoessl, M Davis, S Reske, C Nahmias, AE Lang, ... Annals of neurology 54 (1), 93-101, 2003 | 1011 | 2003 |
| Double-blind study of botulinum toxin in spasmodic torticollis JKC Tsui, AJ Stoessl, A Eisen, S Calne, DB Calne The Lancet 328 (8501), 245-247, 1986 | 822 | 1986 |
| Alpha‐synuclein p. H50Q, a novel pathogenic mutation for Parkinson's disease S Appel‐Cresswell, C Vilarino‐Guell, M Encarnacion, H Sherman, I Yu, ... Movement disorders 28 (6), 811-813, 2013 | 700 | 2013 |
| Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy JA Obeso, M Stamelou, CG Goetz, W Poewe, AE Lang, D Weintraub, ... Movement disorders 32 (9), 1264-1310, 2017 | 686 | 2017 |
| In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease CS Lee, A Samii, V Sossi, TJ Ruth, M Schulzer, JE Holden, J Wudel, ... Annals of Neurology: Official Journal of the American Neurological …, 2000 | 634 | 2000 |
| Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label … WJ Marks, JL Ostrem, L Verhagen, PA Starr, PS Larson, RAE Bakay, ... The Lancet Neurology 7 (5), 400-408, 2008 | 625 | 2008 |
| Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias R de la Fuente-Fernández, V Sossi, Z Huang, S Furtado, JQ Lu, DB Calne, ... Brain 127 (12), 2747-2754, 2004 | 434 | 2004 |
| Neural transplantation for the treatment of Parkinson's disease A Björklund, SB Dunnett, P Brundin, AJ Stoessl, CR Freed, RE Breeze, ... The Lancet Neurology 2 (7), 437-445, 2003 | 426 | 2003 |
| Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease MF Bastide, WG Meissner, B Picconi, S Fasano, PO Fernagut, M Feyder, ... Progress in neurobiology 132, 96-168, 2015 | 419 | 2015 |
| Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease DB Calne, JW Langston, WRW Martin, AJ Stoessl, TJ Ruth, MJ Adam, ... Nature 317 (6034), 246-248, 1985 | 411 | 1985 |
| The role of radiotracer imaging in Parkinson disease B Ravina, D Eidelberg, JE Ahlskog, RL Albin, DJ Brooks, M Carbon, ... Neurology 64 (2), 208-215, 2005 | 377 | 2005 |
| Dopamine release in human ventral striatum and expectation of reward R de la Fuente-Fernández, AG Phillips, M Zamburlini, V Sossi, DB Calne, ... Behavioural brain research 136 (2), 359-363, 2002 | 349 | 2002 |
| DCTN1 mutations in Perry syndrome MJ Farrer, MM Hulihan, JM Kachergus, JC Dächsel, AJ Stoessl, ... Nature genetics 41 (2), 163-165, 2009 | 335 | 2009 |
| Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa RA Hauser, O Rascol, AD Korczyn, A Jon Stoessl, RL Watts, W Poewe, ... Movement Disorders 22 (16), 2409-2417, 2007 | 324 | 2007 |
| DNAJC13 mutations in Parkinson disease C Vilariño-Güell, A Rajput, AJ Milnerwood, B Shah, C Szu-Tu, J Trinh, I Yu, ... Human molecular genetics 23 (7), 1794-1801, 2014 | 321 | 2014 |
| Autosomal dominant parkinsonism associated with variable synuclein and tau pathology ZK Wszolek, RF Pfeiffer, Y Tsuboi, RJ Uitti, RD McComb, AJ Stoessl, ... Neurology 62 (9), 1619-1622, 2004 | 318 | 2004 |
